Search
diclofenac topical (Solaraze, Voltaren gel)
Indications:
- topical NSAID for treatment of actinic keratosis (about 50% effective)
- treatment of osteoarthritis of the knee, ankle, elbow, wrist, & hand [4,7]
- inflammatory conditions of the elbow (lateral epicondylitis)
Contraindications:
- not useful for osteoarthritis of the hip [7]
Caution:
- avoid exposure to sunlight & sunlamps
- avoid applying to broken skin
Dosage:
- apply twice daily for 60-90 days
- in DMSO, Voltaren Gel, apply QID
- may take up to 7 days to work
- Flector patch BID
- Pennsaid, topical solution for osteoarthritis of the knee (Diclofenac Sodium Topical Solution 1.5%)
- 1% Gel
- each upper body area (hand, wrist, or elbow) 2.25 inches (2 grams)
- each lower body area (foot, ankle, or knee) 4.5 inches (4 grams)
Gel: contains 1-3% diclofenac. 1% dispensed in 100 g tubes.
Pharmacokinetics:
- 10% of dose is absorbed through the skin
Adverse effects:
1) better tolerated than 5-fluorouracil (Effudex), but less effective
2) gastrointestinal effects are uncommon
3) hepatotoxicity with 1% topical gel can occur at any time during treatment with diclofenac [5]
4) localized skin rash [6]
Notes: cost about $112/month (2004) [3]
Interactions
drug adverse effects of NSAIDs
monitor with non steroidal anti-inflammatory agents (NSIADs)
Related
actinic (solar) keratosis (AK)
General
diclofenac (Voltaren, Cataflam, Flector patch, Cambia, Pennsaid, Zipsor, Zorvolex)
topical anti-inflammatory agent
References
- Prescriber's Letter 8(2):supplement 2001
- Prescriber's Letter 9(2):11 2002
- Prescriber's Letter 11(5):28 2004
- Barthel HR1, Axford-Gatley RA.
Topical nonsteroidal anti-inflammatory drugs for osteoarthritis.
Postgrad Med. 2010 Nov;122(6):98-106
PMID: 21084786
- FDA MedWatch
Voltaren Gel (diclofenac sodium topical gel) 1% -
Hepatic Effects Labeling Changes
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm193047.htm
- Medical Knowledge Self Assessment Program (MKSAP) 18,
American College of Physicians, Philadelphia 2018
- a Costa BR, Pereira TV, Saadat P et al.
Effectiveness and safety of non-steroidal anti-inflammatory drugs and
opioid treatment for knee and hip osteoarthritis: Network meta-analysis.
BMJ 2021 Oct 12; 375:n2321.
PMID: 34642179 PMCID: PMC8506236 Free PMC article
https://www.bmj.com/content/375/bmj.n2321
- Bariguian Revel F, Fayet M, Hagen M.
Topical diclofenac, an efficacious treatment for osteoarthritis: a narrative review.
Rheumatol Ther. 2020;7(2):217-236
PMID: 32086778 PMCID: PMC7211216 Free PMC article
https://link.springer.com/article/10.1007/s40744-020-00196-6
Components
diclofenac (Voltaren, Cataflam, Flector patch, Cambia, Pennsaid, Zipsor, Zorvolex)